Valuation : Yuhan Corporation

Market Cap 6,073B 4.51B 3.88B 3.65B 3.33B 6.24B 426B 6.26B 43.14B 16.74B 218B 16.93B 16.56B 704B P/E 2026 *
40.9x
P/E 2027 * 29.6x
Enterprise Value 5.99B 4.45M 3.83M 3.6M 3.29M 6.16M 420M 6.17M 42.57M 16.52M 216M 16.71M 16.34M 694M EV / Sales 2026 *
2.56x
EV / Sales 2027 * 2.31x
Free-Float
61.43%
Yield 2026 *
0.7%
Yield 2027 * 0.7%
1 week-4.12%
Current month-2.75%
1 month+8.39%
3 months+5.03%
6 months-17.61%
Current year-27.58%
1 week 80,900
Extreme 80900
84,700
1 month 76,800
Extreme 76800
87,500
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 19/03/2021
Director of Finance/CFO 58 -
President 67 15/03/2024
Director TitleAgeSince
Chairman 74 19/03/2021
Director/Board Member 71 20/03/2015
Director/Board Member 62 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/06/25 Buy

Chairperson

200 0.0002%
25/06/25 Buy

Chief Executive Officer

720 0.0009%
24/06/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.12%-31.60%+22.10% 4.51B
-1.32%+1.33%+77.46%+39.83% 371B
-1.45%-3.14%+24.01%-19.99% 68.64B
-0.51%+4.59%+47.06%+169.41% 12.51B
-1.09%-9.76%-8.26%-9.30% 8.06B
+0.23%-1.59%-20.70%+6.52% 5.04B
-0.35%-3.11%-33.77%+0.49% 3.07B
-1.00%-0.46%-5.37%+37.06% 2.53B
-0.50%-3.98%-24.35%-17.31% 2B
+0.12%-1.96%-25.07%-14.84% 1.7B
Average -0.59%-1.64%-0.06%+21.40% 47.89B
Weighted average by Cap. -1.27%+0.86%+63.57%+32.60%

Financials

2026 *2027 *
Net sales 2,340B 1.74B 1.5B 1.41B 1.29B 2.4B 164B 2.41B 16.62B 6.45B 84.18B 6.53B 6.38B 271B 2,556B 1.9B 1.63B 1.54B 1.4B 2.63B 179B 2.63B 18.15B 7.04B 91.92B 7.13B 6.97B 296B
Net income 154B 114M 98.22M 92.41M 84.42M 158M 10.78B 158M 1.09B 424M 5.53B 429M 419M 17.81B 206B 153M 132M 124M 113M 212M 14.44B 212M 1.46B 568M 7.41B 574M 562M 23.86B
Net Debt -80.13B -59.5M -51.2M -48.17M -44.01M -82.32M -5.62B -82.55M -569M -221M -2.88B -223M -219M -9.29B -162B -120M -103M -97.28M -88.87M -166M -11.34B -167M -1.15B -446M -5.82B -451M -441M -18.75B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
04/09/26 ₩81,400.00 0.00% 108,985
03/09/26 ₩81,400.00 +0.12% 256,221
02/09/26 ₩81,300.00 -1.69% 188,082
01/09/26 ₩82,700.00 -1.19% 136,338
31/08/26 ₩83,700.00 -1.41% 640,942
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
81,400.00KRW
Average target price
120,111.11KRW
Spread / Average Target
+47.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock